BVS vs DCTH: stock comparison and AI forecast
Bioventus Inc. (BVS) and Delcath Systems, Inc. (DCTH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BVS Bioventus Inc.
- Market Cap
- $727M
- P/E Ratio
- 29.5x
- Size
- small-cap
- AI Forecast
DCTH Delcath Systems, Inc.
- Market Cap
- $527M
- P/E Ratio
- 213.3x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BVS is 1.4 times larger than DCTH by market capitalization ($727M against $527M).
- BVS trades at 29.5 times trailing earnings, DCTH at 213.3 times.
- BVS carries 1.59 times debt per unit of equity, against 0.13 times for DCTH.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BVS | DCTH |
|---|---|---|
| Market Cap | $727M | $527M |
| P/E Ratio | 29.47x | 213.27x |
| P/B Ratio | 3.02x | 4.35x |
| EPS | $0.36 | $0.07 |
| Book Value/Share | $3.51 | $3.43 |
| Revenue/Share | $8.55 | $2.70 |
| FCF/Share | $1.24 | $0.50 |
Profitability & Margins
| Metric | BVS | DCTH |
|---|---|---|
| ROE | – | 0.4% |
| ROA | – | 0.4% |
| ROIC | 11.0% | -1.5% |
| Gross Margin | 68.7% | 87.0% |
| Operating Margin | 9.7% | -1.9% |
| Net Margin | – | 0.6% |
| EBT Margin | 6.8% | 1.4% |
| Tax Rate | -60.3% | 58.8% |
Financial Health
| Metric | BVS | DCTH |
|---|---|---|
| Current Ratio | 1.68x | 9.83x |
| Quick Ratio | 1.16x | 8.95x |
| D/E Ratio | 1.59x | 0.13x |
| Financial Leverage | 2.80x | 1.13x |
| Interest Coverage | – | 13.7x |
| Working Capital | $108M | $117M |
Cash Flow
| Metric | BVS | DCTH |
|---|---|---|
| Operating Cash Flow | $87M | $20M |
| Free Cash Flow | $85M | $18M |
| Capital Spending | -$2M | -$2M |
| OCF Growth YoY | 56.1% | 303.9% |
| FCF Growth YoY | 58.9% | 352.7% |
| FCF/Sales | 14.5% | 18.4% |
| CapEx/Sales | 0.4% | 2.2% |
Operational Efficiency
| Metric | BVS | DCTH |
|---|---|---|
| Asset Turnover | 0.87x | 0.70x |
| Receivables Turnover | 4.2x | 6.0x |
| Inventory Turnover | 2.2x | 1.1x |
| Fixed Assets Turnover | 60.3x | 23.7x |
| Days Sales Outstanding | 86 days | 61 days |
| Days Inventory | 165 days | 346 days |
| Payables Period | 51 days | 118 days |
| Cash Conversion Cycle | 200 days | 289 days |
Income Statement
| Metric | BVS | DCTH |
|---|---|---|
| Total Revenue | $586M | $95M |
| Operating Income | $57M | -$2M |
| Net Income | – | $530K |
| R&D Expense | $12M | $38M |
| SG&A Expense | $327M | $47M |
| Cost of Goods Sold | $183M | $12M |
Dividend & Shareholder Information
| Metric | BVS | DCTH |
|---|---|---|
| Shares Outstanding | 68M | 35M |
| Net Income Growth | – | -76.2% |
BVS vs DCTH: stock comparison and AI forecast
Which is bigger, BVS or DCTH?
BVS is 1.4 times larger than DCTH by market capitalization ($727M against $527M).
Which is cheaper on earnings, BVS or DCTH?
BVS trades at 29.5 times trailing earnings, DCTH at 213.3 times.
Which one does Intratio's AI model rank higher, BVS or DCTH?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.